These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 35736358)
21. Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995. Milán T; Pukkala E; Verkasalo PK; Kaprio J; Jansén CT; Koskenvuo M; Teppo L Int J Cancer; 2000 Jul; 87(2):283-8. PubMed ID: 10861488 [TBL] [Abstract][Full Text] [Related]
22. Cutaneous malignancies: BCC, SCC, and MM. Vargo N Dermatol Nurs; 2006 Apr; 18(2):183, 200. PubMed ID: 16708685 [No Abstract] [Full Text] [Related]
32. Parkinson's Disease, Melanoma, and Keratinocyte Carcinoma: A Population-Based Study. Lerman S; Amichai B; Weinstein G; Shalev V; Chodick G Neuroepidemiology; 2018; 50(3-4):168-173. PubMed ID: 29566384 [TBL] [Abstract][Full Text] [Related]
33. Dermoscopy in the diagnosis and management of basal cell carcinoma. Lallas A; Apalla Z; Ioannides D; Argenziano G; Castagnetti F; Moscarella E; Longo C; Palmieri T; Ramundo D; Zalaudek I Future Oncol; 2015 Nov; 11(22):2975-84. PubMed ID: 26450622 [TBL] [Abstract][Full Text] [Related]
34. Association of Shiny White Blotches and Strands With Nonpigmented Basal Cell Carcinoma: Evaluation of an Additional Dermoscopic Diagnostic Criterion. Navarrete-Dechent C; Bajaj S; Marchetti MA; Rabinovitz H; Dusza SW; Marghoob AA JAMA Dermatol; 2016 May; 152(5):546-52. PubMed ID: 26792406 [TBL] [Abstract][Full Text] [Related]
35. Is early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening. Hoorens I; Vossaert K; Ongenae K; Brochez L Br J Dermatol; 2016 Jun; 174(6):1258-65. PubMed ID: 26872563 [TBL] [Abstract][Full Text] [Related]
36. Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in The Netherlands. van Hattem S; Aarts MJ; Louwman WJ; Neumann HA; Coebergh JW; Looman CW; Nijsten T; de Vries E Br J Dermatol; 2009 Oct; 161(4):840-5. PubMed ID: 19438849 [TBL] [Abstract][Full Text] [Related]
37. Epidemiological and pathological aspects of skin cancer in North East of Romania. Andrese E; Solovăstru LG; Taranu T; Iancu LS Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):457-62. PubMed ID: 25076715 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of prospectively collected presenting signs/symptoms of biopsy-proven melanoma, basal cell carcinoma, squamous cell carcinoma, and seborrheic keratosis in an elderly male population. Askari SK; Schram SE; Wenner RA; Bowers S; Liu A; Bangerter AK; Warshaw EM J Am Acad Dermatol; 2007 May; 56(5):739-47. PubMed ID: 17258839 [TBL] [Abstract][Full Text] [Related]
39. Comparative aspects of melanoma and non-melanoma skin cancers in Japan. Ikeda S; Kiyohara Y; Mizutani H J Invest Dermatol; 1989 May; 92(5 Suppl):204S-209S. PubMed ID: 2715651 [TBL] [Abstract][Full Text] [Related]
40. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach. Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]